Events

Bio Integrates 2021

20 May 2021

Nathalie Huther (Senior Director of Business Development, Europe) of Arcinova, a Quotient Sciences business, will be joining the panel discussion "It ain’t what you do, it’s the way that you do it” on 20th May: Networking session 2.

This roundtable discussion will explore how CDMOs can differentiate their offering in a market place where offerings appear similar. The discussion will also explore how biotech companies chose the right one to work with.

Event Details:

Event: Bio Integrates
Date: May 20th, 2021
Location: Virtual event
Conference Website

Resources

See our related resources

Whitepaper

Assessing the Financial Impact of Translational Pharmaceutics®

Tufts Center for the Study of Drug Development (CSDD) white paper sharing study results that indicate Quotient Sciences’ Translational Pharmaceutics® platform reduces development times by more than 12 months and lowers R&D costs by more than $100 million per approved new drug, compared to traditional multi-vendor development paradigms.

Info Sheet

Translational Pharmaceutics

Quotient Sciences helps you achieve your goals by enabling precise formulation development, streamlined manufacturing, quick pivot to clinical data and a significantly faster transition through drug development.

Info Sheet

First-in-Human to Proof-of-Concept

Our Translational Pharmaceutics approach enables First-in-Human studies by re-engineering the transition of your drug molecule into clinical development and shortening the timeline to Proof-of-Concept.

Formulation Development Drug Substance Clinical Trial Manufacturing Commercial Manufacturing Bioanalysis Clinical Pharmacology Data Sciences Drug Development Consulting

Ask us a question

Suggested searches